Modular Medical, Inc. (MODD) Stock Price, Financials & Summary

Price chart

Sep 18Sep 23Sep 28Oct 1Oct 6Oct 9Oct 14Oct 19

Key dataOct 19, 2026

Open$2.37

From 52W high−88.65%

Volume65295.00

Market cap$19.66M

P/E (TTM)—

P/S (TTM)—

Div yield—

Key dataOct 19, 2026

Open

$2.37

From 52W high

−88.65%

Volume

65295.00

Market cap

$19.66M

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−0.6x

P/E (TTM)

—

RSI (14)

44.6

MomentumView details →

1D Return

−10.58%

YTD Return

−79.99%

SummaryUpdated Jun 1, 2026

Modular Medical, Inc. (NASDAQ:MODD) is a development-stage medical device company founded to revolutionize diabetes management through innovative insulin pump technology. The company went public in February 2022 and is headquartered in San Diego, California. Since its IPO, Modular Medical has been focused on developing and commercializing next-generation insulin delivery systems designed to improve adoption rates among diabetic patients who require insulin therapy.

Ask drillr about Modular Medical, Inc. →

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

−0.6x

EV/Sales

—

P/S (TTM)

—

P/B (TTM)

1.8x

ProfitabilityView details →

Gross Margin

—

Net Margin

—

EBITDA Margin

—

ROE (TTM)

−260.37%

ROA (TTM)

−228.73%

Asset Turnover

0.00x

GrowthView details →

Revenue YoY

—

EPS YoY

+10.50%

FCF YoY

—

Revenue CAGR 3Y

—

EPS CAGR 3Y

+19.22%

EBITDA YoY

−27.07%

MomentumView details →

1D Return

−10.58%

YTD Return

−79.99%

1Y Return

−88.01%

RSI (14)

44.6

vs 50D SMA

−17.19%

vs 200D SMA

−62.10%

Capital & dividendView details →

Debt/Equity

0.03x

Current Ratio

3.25x

Quick Ratio

3.25x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

−$1.19

EPS Surprise

—

Beats (12Q)

3/12

Next Q EPS Est

—

Avg Surprise (4Q)

−4.96%

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

0.00

Net Income (TTM)

−28.03M

Op. CF (TTM)

−24.35M

Next earningsDec 2, 2026 →

Latest newsMore news →

Modular Medical, Inc. directors Jeffrey Goldberg and Carmen Volkart departed the board upon the expiry of their terms.20d ago

Modular Medical announced it secured a contract with a national U.S. pharmacy benefit manager, making its Pivot insulin delivery system available through the PBM.46d ago

Similar companies

InspireMD, Inc.NSPR PAVmed Inc.PAVM Accuray IncorporatedARAY Lifeward Ltd.LFWD Cytosorbents CorporationCTSO HeartSciences Inc.HSCS Find similar companies →

Latest newsMore news →

Modular Medical, Inc. directors Jeffrey Goldberg and Carmen Volkart departed the board upon the expiry of their terms.20d ago Modular Medical announced it secured a contract with a national U.S. pharmacy benefit manager, making its Pivot insulin delivery system available through the PBM.46d ago Modular Medical, Inc. announced on Thursday that the U.S. Food & Drug Administration cleared software enhancements to its Pivot insulin delivery system.47d ago